… Indeed, these cells seem to be involved in the secretion of R-spondin3, taking part in
stem cell activity; moreover, during the process of mucosal inflammation and regeneration, …

Patients with hepatocellular carcinoma should be managed with a multidisciplinary approach
framed in a network where all the diagnostic techniques and therapeutic resources are …

The aim of this study was to evaluate the incidence, radiographic appearance, time of onset,
outcome and risk factors of non-infectious and infectious pulmonary complications following …

A multicenter analysis was conducted to evaluate the main prognostic factors driving survival
after radioembolization using yttrium‐90–labeled resin microspheres in patients with …

Background: Transcatheter arterial chemoembolisation (TACE) is the treatment of choice for
intermediate stage hepatocellular carcinoma (HCC). Doxorubicin-loaded drug-eluting …

In a prospective study, we examined the impact of arterial hypervascularity, as established
by the European Association for the Study of the Liver (EASL) recommendations, as a …

Background Incidental discovery of adrenal masses has increased over the past few years.
Mild alterations in cortisol secretion without clinical signs of overt hypercortisolism (…

Conventional criteria for liver transplantation for patients with hepatocellular carcinoma are
single HCC ≤ 5 cm or less than or equal to three HCCs ≤ 3 cm. We prospectively evaluated …

Background: This multi-centre phase II clinical trial is the first prospective evaluation of
radioembolisation of patients with colorectal liver metastases (mCRC) who failed previous …

Purpose To determine the accuracy of imaging features, such as tumor dimension, multinodularity,
nonsmooth tumor margins, peritumoral enhancement, and radiogenomic algorithm …